Bioxcel Therapeutics, INC. (BTAI) — SC 13G/A Filings
All SC 13G/A filings from Bioxcel Therapeutics, INC.. Browse 3 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (3)
- SC 13G/A Filing — Sep 10, 2024
-
FMR LLC & Abigail Johnson Disclose 8.6% Stake in BioXcel Therapeutics
— Feb 9, 2024 Risk: medium
FMR LLC, a major investment firm, and its principal owner, Abigail P. Johnson, have updated their ownership stake in BioXcel Therapeutics, Inc. (BTAI). As of Fe -
Adage Capital Partners Cuts BioXcel Therapeutics Stake to 1.1%
— Feb 7, 2024
Adage Capital Partners, L.P. filed an amended SC 13G/A on February 7, 2024, disclosing its beneficial ownership in BioXcel Therapeutics, Inc. As of December 31,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX